{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T07:40:05Z","timestamp":1782978005008,"version":"3.54.5"},"reference-count":12,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","prd-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Parkinsonism &amp; Related Disorders"],"published-print":{"date-parts":[[2021,5]]},"DOI":"10.1016\/j.parkreldis.2021.03.014","type":"journal-article","created":{"date-parts":[[2021,3,27]],"date-time":"2021-03-27T12:23:13Z","timestamp":1616847793000},"page":"10-14","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":21,"special_numbering":"C","title":["Changes in prefrontal cortical activity and turning in response to dopaminergic and cholinergic therapy in Parkinson's disease: A randomized cross-over trial"],"prefix":"10.1016","volume":"86","author":[{"given":"Rodrigo","family":"Vitorio","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samuel","family":"Stuart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Giritharan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph","family":"Quinn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John G.","family":"Nutt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martina","family":"Mancini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"7","key":"10.1016\/j.parkreldis.2021.03.014_bib1","first-page":"697","article-title":"Gait impairments in Parkinson's disease, the Lancet","volume":"18","author":"Mirelman","year":"2019","journal-title":"Neurology"},{"issue":"25","key":"10.1016\/j.parkreldis.2021.03.014_bib2","doi-asserted-by":"crossref","first-page":"2994","DOI":"10.1080\/09638288.2018.1483429","article-title":"Turning problems and freezing of gait in Parkinson's disease: a systematic review and meta-analysis","volume":"41","author":"Spildooren","year":"2019","journal-title":"Disabil. Rehabil."},{"key":"10.1016\/j.parkreldis.2021.03.014_bib3","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.parkreldis.2019.02.017","article-title":"Overview of the cholinergic contribution to gait, balance and falls in Parkinson's disease","volume":"63","author":"Morris","year":"2019","journal-title":"Park. Relat. Disord."},{"issue":"11","key":"10.1016\/j.parkreldis.2021.03.014_bib4","doi-asserted-by":"crossref","first-page":"2019","DOI":"10.1002\/mds.28214","article-title":"Prefrontal cortex activity and gait in Parkinson's disease with cholinergic and dopaminergic therapy","volume":"35","author":"Stuart","year":"2020","journal-title":"Mov. Disord."},{"issue":"3","key":"10.1016\/j.parkreldis.2021.03.014_bib5","first-page":"249","article-title":"Rivastigmine for gait stability in patients with Parkinson's disease (ReSPonD): a randomised, double-blind, placebo-controlled, phase 2 trial, the Lancet","volume":"15","author":"Henderson","year":"2016","journal-title":"Neurology"},{"key":"10.1016\/j.parkreldis.2021.03.014_bib6","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.parkreldis.2019.10.022","article-title":"Effects of augmenting cholinergic neurotransmission on balance in Parkinson's disease","volume":"69","author":"Mancini","year":"2019","journal-title":"Park. Relat. Disord."},{"issue":"13","key":"10.1016\/j.parkreldis.2021.03.014_bib7","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1056\/NEJM199409293311310","article-title":"Falls","volume":"331","author":"Cummings","year":"1994","journal-title":"N. Engl. J. Med."},{"issue":"10","key":"10.1016\/j.parkreldis.2021.03.014_bib8","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1177\/1545968316650426","article-title":"The role of the frontal lobe in complex walking among patients with Parkinson's disease and healthy older adults: an fNIRS study","volume":"30","author":"Maidan","year":"2016","journal-title":"Neurorehabilitation Neural Repair"},{"issue":"536","key":"10.1016\/j.parkreldis.2021.03.014_bib9","article-title":"Pre-frontal cortical activity during walking and turning is reliable and differentiates across young, older adults and people with Parkinson's disease","volume":"10","author":"Stuart","year":"2019","journal-title":"Front. Neurol."},{"issue":"4","key":"10.1016\/j.parkreldis.2021.03.014_bib10","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1038\/nrneurol.2017.27","article-title":"Cognitive decline in Parkinson disease","volume":"13","author":"Aarsland","year":"2017","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.parkreldis.2021.03.014_bib11","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/j.neuroscience.2016.11.045","article-title":"The clinical significance of freezing while turning in Parkinson's disease","volume":"343","author":"Mancini","year":"2017","journal-title":"Neuroscience"},{"issue":"4","key":"10.1016\/j.parkreldis.2021.03.014_bib12","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1016\/j.neuroimage.2009.12.060","article-title":"Real versus imagined locomotion: a [18F]-FDG PET-fMRI comparison","volume":"50","author":"la Fougere","year":"2010","journal-title":"Neuroimage"}],"container-title":["Parkinsonism &amp; Related Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1353802021001073?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1353802021001073?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,23]],"date-time":"2025-10-23T00:21:36Z","timestamp":1761178896000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1353802021001073"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5]]},"references-count":12,"alternative-id":["S1353802021001073"],"URL":"https:\/\/doi.org\/10.1016\/j.parkreldis.2021.03.014","relation":{},"ISSN":["1353-8020"],"issn-type":[{"value":"1353-8020","type":"print"}],"subject":[],"published":{"date-parts":[[2021,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Changes in prefrontal cortical activity and turning in response to dopaminergic and cholinergic therapy in Parkinson's disease: A randomized cross-over trial","name":"articletitle","label":"Article Title"},{"value":"Parkinsonism & Related Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.parkreldis.2021.03.014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}